April 19, 2016
Research at Group Health points to bupropion (Wellbutrin) as first choice for overweight and obese patients with depression.
Find by Date
Researcher Last Name
Randomized controlled trial including peer support helps patients at Group Health and Swedish Medical Center.
Depression, mental health
Study leader Dr. David Arterburn will use PCORnet, new national clinical research network, to speed results.
Vaccine Treatment and Evaluation Unit tests real-world use to prepare for H7N9.
vaccine, vaccination, immunization, H7N9 bird flu
National Institute on Aging renews funding for long-running 'living laboratory.'
aging, ACT study, brain science
Drs. Larson and Crane co-lead Group Health-University of Washington collaboration learning how to promote healthy aging.
View more videos
Group Health Research Institute